These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Therapeutic use of fructose: professional freedom, 'pharmacovigilance' and Europe. Cox TM QJM; 1995 Apr; 88(4):225-7. PubMed ID: 7796072 [No Abstract] [Full Text] [Related]
26. [Comment on the contribution by H. Götze and A. Mahdi. Fructose malabsorption and dysfunctional abdominal complaints]. Classen M; Nielinger J Monatsschr Kinderheilkd; 1993 Apr; 141(4):276. PubMed ID: 8487786 [No Abstract] [Full Text] [Related]
36. A case of fatal hereditary fructose intolerance. Misleading information of formula composition. von Ruecker A; Endres W; Shin YS; Butenandt I; Steinmann B; Gitzelmann R Helv Paediatr Acta; 1981; 36(6):599-600. PubMed ID: 7333867 [No Abstract] [Full Text] [Related]
37. [Adults with hereditary fructose intolerance: risks of fructose infusion]. Steegmanns I; Rittmann M; Bayerl JR; Gitzelmann R Dtsch Med Wochenschr; 1990 Apr; 115(14):539-41. PubMed ID: 1969793 [TBL] [Abstract][Full Text] [Related]
38. [Ketone bodies in the blood during sorbitol infusion]. Matzkies F; Berg G; Bickel H; Sailer D Fortschr Med; 1975 Sep; 93(26):1230-3. PubMed ID: 1205448 [TBL] [Abstract][Full Text] [Related]
39. [Effects of high dosage sorbitol infusions on the carbohydrate, fat, and uric acid metabolism, acid-base balance, and the electrolyte concentration in serum and urine of healthy men (author's transl]. Berg G; Matzkies F; Heid H Dtsch Med Wochenschr; 1974 Nov; 99(46):2352-6. PubMed ID: 4430291 [No Abstract] [Full Text] [Related]
40. [Clinical heterogeneity in fructose intolerance]. Borrone C; Lamedica G; Di Rocco M; Canini S; Zanelli C Pediatr Med Chir; 1982; 4(3):195-202. PubMed ID: 7170190 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]